Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
4.820
-0.100 (-2.03%)
Jan 26, 2026, 4:00 PM EST - Market closed
Evolus Employees
Evolus had 329 employees as of September 30, 2025. The number of employees increased by 7 or 2.17% compared to the same quarter last year.
Employees
329
Change
7
Growth
2.17%
Revenue / Employee
$868,763
Profits / Employee
-$178,000
Market Cap
312.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 329 | 7 | 2.17% |
| Jun 30, 2025 | 394 | 90 | 29.61% |
| Mar 31, 2025 | 372 | 93 | 33.33% |
| Dec 31, 2024 | 332 | 59 | 21.61% |
| Sep 30, 2024 | 322 | 76 | 30.89% |
| Jun 30, 2024 | 304 | 89 | 41.40% |
| Mar 31, 2024 | 279 | 55 | 24.55% |
| Dec 31, 2023 | 273 | 58 | 26.98% |
| Sep 30, 2023 | 246 | 33 | 15.49% |
| Jun 30, 2023 | 215 | 41 | 23.56% |
| Mar 31, 2023 | 224 | 50 | 28.74% |
| Dec 31, 2022 | 215 | 48 | 28.74% |
| Sep 30, 2022 | 213 | 64 | 42.95% |
| Jun 30, 2022 | 174 | 44 | 33.85% |
| Mar 31, 2022 | 174 | 68 | 64.15% |
| Dec 31, 2021 | 167 | 48 | 40.34% |
| Sep 30, 2021 | 149 | 24 | 19.20% |
| Jun 30, 2021 | 130 | 3 | 2.36% |
| Mar 31, 2021 | 106 | -114 | -51.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,139 |
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
| Organogenesis Holdings | 869 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Akebia Therapeutics | 181 |
| Aquestive Therapeutics | 142 |
EOLS News
- 17 days ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Business Wire
- 6 weeks ago - AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings - Seeking Alpha
- 2 months ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evolus Reports Third Quarter 2025 Financial Results - Business Wire
- 3 months ago - Evolus to Participate in 2025 Stifel Healthcare Conference - Business Wire
- 3 months ago - Evolus to Report Third Quarter Financial Results on November 5, 2025 - Business Wire
- 4 months ago - Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch - PRNewsWire